CLINICAL TRIALS NETWORK OF TENNESSEE (CTN2)
Tennessee's state-wide multi-site clinical trial facilitator - Site operated, academically supported, powered by a robust research enterprise data warehouse, for superior performance and increased sponsor engagement.
Scroll Down
Serving as a beacon for industry-sponsored research at The University of Tennessee Health Science Center (UTHSC), CTN2’s mission is to advance research by aggregating and supporting research conducted by UTHSC faculty investigators across the State for the benefit of the citizens of Tennessee.
The CTN2 Difference
CTN2’s focus is deeply rooted in the advancement and support of research for the University of Tennessee. CTN2’s structure allows for the aggregation of research expenditures, improving UT’s ranking and reputation and making participating hospitals, practice plans, and medical school more attractive in recruiting and retaining research professionals and trial sponsors. In addition, the TN-EDW data on potential clinical trial participants will allow clinical trial sponsors efficient assessment of and access to multiple Tennessee participating hospitals and clinical care networks.
OUR SERVICES
CTN2 offers unique benefits to all the different audiences served by its network.
CTN2 aggregates a number of different health care providers/clinics to provide clinical trial related services to Sponsors seeking access to multiple sites to conduct a clinical trial.
FOR
SPONSORS & CRO'S
Research is critical to advancing medicine and patient care. Through CTN2, patients will have more treatment options available to them in the State of Tennessee.
FOR
PATIENTS
CTN2 provides university-based credibility and recruitment opportunities while employing expert contract capabilities.
FOR
PHYSICIANS
CTN2 supports site-based activities within its network of participating sites by providing expertise in feasibility, contracting and budgeting, regulatory, and billing.
FOR
SITES
Reach out to us.
Questions about our organization, structure, or participation benefits? We'd love to hear from you!